跳至主要内容
临床试验/JPRN-UMIN000018630
JPRN-UMIN000018630已完成未知

The feasibility study of pharmacokinetics and immune response of T-DM1 in metastatic/recurrent HER2-positive breast cancer - The feasibility study of pharmacokinetics and immune response of T-DM1 in metastatic/recurrent HER2-positive breast cancer

ational Cancer Center Hospital0 个研究点目标入组 20 人开始时间: 2015年8月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • a) Brain metastasis with clinical symptoms b) Uncontrollable body fluid c) Concurrent serious disease or condition Active infection concurrent serious psychiatric disorder Ileus, breeding Uncontrollable angina and mycardial infarction within 3 months, severe heart disease with heart failure d) pregnant or lactating women e) Patient considered irrelevant by attending physician for the study

研究者

相似试验